Patently controversial: markets, morals, and the President's proposal for embryonic stem cell research.
This essay considers the implications of President George W. Bush's proposal for human embryonic stem cell research. Through the perspective of patent law, privacy, and informed consent, we elucidate the ongoing controversy about the moral standing of human embryonic stem cells and their derivatives and consider how the inconsistencies in the president's proposal will affect clinical practice and research.
Fins
Joseph J
JJ
Division of Medical Ethics, Weill Medical College of Cornell University, New York, NY, USA.
Schachter
Madeleine
M
D035843:Biomedical Research / Q000191:economics* / Q000331:legislation & jurisprudence; D002460:Cell Line; D004247:DNA; D033041:Embryo Research / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence*; D004622:Embryo, Mammalian / Q000166:cytology; D035082:Federal Government; D005380:Financing, Government; D005610:Freedom; D030661:Genetic Privacy; D006801:Humans; D007258:Informed Consent; D009014:Morals; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011057:Politics; D017149:Private Sector; D011640:Public Policy; D012109:Research Support as Topic; D013234:Stem Cells; D014019:Tissue Donors; D014481:United States
D004247:DNA